Sarepta Therapeutics, Inc. SRPT Royalty Revenue — Royalty Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept srpt:RoyaltyRevenue.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s royalty revenue — royalty revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s royalty revenue — royalty revenue?
- Sarepta Therapeutics, Inc. (SRPT) reported royalty revenue — royalty revenue of $4.18M in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s royalty revenue — royalty revenue changed year-over-year?
- Sarepta Therapeutics, Inc.'s royalty revenue — royalty revenue increased by 5.8% year-over-year, from $3.95M to $4.18M.
- What does royalty revenue — royalty revenue mean?
- This metric represents the income generated from licensing intellectual property or technology to third-party partners. It reflects the monetization of proprietary assets through external commercialization efforts rather than direct product sales. Growth in this area indicates successful technology out-licensing and the expansion of passive revenue streams.